Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the toxic activity of many environmental xenobiotics. However, its role in innate immune responses during viral infection is not fully understood. Here we demonstrate that constitutive AHR signaling negatively regulates the type I interferon (IFN-I) response during infection with various types of virus. Virus-induced IFN-β production was enhanced in AHR-deficient cells and mice and resulted in restricted viral replication. We found that AHR upregulates expression of the ADP-ribosylase TIPARP, which in turn causes downregulation of the IFN-I response. Mechanistically, TIPARP interacted with the kinase TBK1 and suppressed its activity by ADP-ribosylation. Thus, this study reveals the physiological importance of endogenous activation of AHR signaling in shaping the IFN-I-mediated innate response and, further, suggests that the AHR-TIPARP axis is a potential therapeutic target for enhancing antiviral responses.
AHR was originally discovered as a xenobiotic sensor that mediates the toxicity of the persistent environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), more commonly known as dioxin [1] [2] [3] [4] . Activation of AHR induces its target genes, including those encoding cytochrome P4501A1, cytochrome P4501B1, AHR repressor, TCDD-inducible poly(ADP-ribose)polymerase (TIPARP) and aldehyde dehydrogenase 1A3 (refs. 1,2,5-9), which are involved in the adaptive metabolism of xenobiotic compounds. This property of AHR has been implicated in host defense against bacterial infection, as certain bacterial pigmented virulence factors are AHR agonists that are subsequently metabolized by AHR-regulated drug-metabolizing enzymes 10 . Studies of AHR-deficient mice have identified important physiological roles for AHR in response to endogenous ligands in cell cycle regulation, cell differentiation and immune responses 8, [11] [12] [13] [14] . In relation to this, several putative endogenous ligands for the AHR have also been reported, including heme metabolites, arachidonic acids or leukotrienes and tryptophan metabolites, such as 6-formylindolo(3,2-b)carbazole (FICZ) and kynurenine (Kyn) 2, 8, 15 .
There has been increased interest in understanding the role of AHR in immunity. Several reports, most of which are based mainly on experiments with dioxin treatment, have shown that the AHR is involved in the differentiation and/or function of T cells, macrophages and dendritic cells 7, 9, 11, [16] [17] [18] [19] [20] [21] . AHR has been implicated in the control of acute graft-versus-host disease and autoimmunity 11, 12, 21 . Dioxinactivated AHR also reduces the survival rate of mice infected with influenza A virus 22, 23 and indirectly suppresses the proliferation and differentiation of virus-specific CD8 + T cells via its regulatory role in dendritic cells 24 . FICZ and dioxin diminish CD8 + T cell responsiveness, whereas dioxin, but not FICZ, affects neutrophil recruitment or pulmonary inducible nitric oxide synthase (iNOS) induction in response to influenza virus infection 25 .
Tryptophan metabolites such as Kyn are upregulated during inflammation and/or tumor progression in several types of immune and tumor cells through the catalytic activity of tryptophan dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO), which catalyze the first step in the formation of Kyn from tryptophan 2, 9 . This increase in Kyn leads to an increase in regulatory T cells (T reg cells), inducing immune tolerance 26 . However, there are limited studies investigating the role of constitutive AHR signaling by endogenous ligands for the regulation of immune responses.
We focused here on the effect of constitutive AHR signaling on IFN-I, a crucial player in the innate immune response that confers an 6 8 8 VOLUME 17 NUMBER 6 JUNE 2016 nature immunology A r t i c l e s antiviral state in cells on viral infection 27 . IFN-I is strongly induced after the activation of a subset of pattern-recognition receptors (PRRs), such as RIG-I, through their recognition of virus-derived nucleic acids [28] [29] [30] [31] . RIG-I and cyclic GMP-AMP synthase (cGAS) are cytosolic RNA and DNA sensors, respectively, that induce IFN-I production through a common pathway involving the kinase TBK1 and the transcription factor IRF- 3 (refs. 27-36) .
In the present study we found that the IFN-I response was markedly enhanced in AHR-deficient cells during infection with various types of virus. We also identified TIPARP as an AHR target that post-translationally ADP-ribosylates TBK1, playing an essential part in AHR-mediated regulation of IFN-I production. Our findings thus demonstrate a link between AHR signaling and innate signaling for the modulation of interferon-mediated antiviral response during viral infection.
RESULTS

Endogenous AHR signaling modulates IFN-I response
We first examined the involvement of AHR in a virally induced IFN-I response. Compared to wild-type mouse embryonic fibroblasts (MEFs), AHR-deficient (Ahr −/− ) MEFs showed marked enhancement of the IFN-I response against infection with RNA and DNA viruses including vesicular stomatitis virus (VSV), influenza virus (A/Puerto Rico/8/1934 H1N1 strain) (FluV), Newcastle disease virus (NDV), Sendai virus (SeV), encephalomyocarditis virus (EMCV) and herpes simplex virus-1 (HSV-1) (Fig. 1a and Supplementary Fig. 1a ). Similar observations were made in Ahr −/− MEFs stimulated with microbial-associated molecular patterns (MAMPs; 5′-triphosphate RNA (3pRNA), poly(rI:rC) and double-stranded vaccinia virus (dsVACV) 70-mer) ( Supplementary Fig. 1b,c) . This phenotype was rescued by overexpression of wild-type AHR in Ahr −/− MEFs ( Supplementary  Fig. 1c,d ). We also found that AHR deficiency enhanced the phosphorylation of TBK1 and IRF-3, essential mediators of IFN-I production (Supplementary Fig. 1e ). Consistent with the enhanced IFN-I response, viral titers were significantly reduced in Ahr −/− MEFs at 24 h after infection with VSV or FluV (Fig. 1b) . We next evaluated the functional role of AHR in bone-marrow-derived macrophages (BMDMs) and splenocytes derived from wild-type and Ahr −/− mice. Similarly to our findings with MEFs, IFN-β production was higher in Ahr −/− BMDMs than in wild-type cells after FluV infection or nucleic acid stimulation (3pRNA or extracellular poly(rI:rC)) ( Fig. 1c and Supplementary Fig. 1f,g ).
In addition, Ahr −/− C57BL/6N mice showed increased IFN-β protein at 36 h after FluV infection, and this was accompanied by markedly reduced viral titers (Fig. 1d) . The expression of several AHR target genes was significantly lower (P < 0.01, Student's t-test) in Ahr −/− MEFs than in wild-type MEFs, and consistently, their expression levels were also reduced in wild-type MEFs treated with the AHR-specific antagonist CH-223191 (ref. 37) compared with the control group (DMSO) (Supplementary Fig. 1h ), suggesting that AHR signaling is constitutively activated. We next examined whether the AHR-mediated effect on IFN-I response was dependent on its endogenous ligand(s). CH-223191 treatment upregulated the IFN-β response to viral infection or stimulation with 3pRNA or cyclic GMP-AMP (cGAMP) ( Fig. 1e and Supplementary Fig. 1i,j) . These results suggest that IFN-I production in response to viral infection is negatively regulated by endogenously activated AHR signaling. In support of this idea, the IFN-I response to infection with viruses or stimulation with 3pRNA was significantly suppressed by treatment with endogenous AHR ligands Kyn or FICZ (Fig. 2a,b and Supplementary  Fig. 2a) . In contrast, IFN-β production in response to VSV infection was upregulated in wild-type MEFs after pretreatment with 680C91, a specific inhibitor of TDO that catalyzes the first step in the formation of Kyn from tryptophan 38 ( Fig. 2c and Supplementary Fig. 2b) , an effect not observed in Ahr −/− MEFs (Fig. 2c) . We obtained similar results in Ahr −/− BMDMs on treatment with an IDO inhibitor (1-MT) (Supplementary Fig. 2c ). Moreover, intraperitoneal (i.p.) pretreatment with FICZ resulted in a marked reduction in serum IFN-β protein at 12 h after VSV infection in wild-type mice, which was consistent with elevated viral titers (Fig. 2d) , whereas this effect was (Fig. 2d) . VSV infection did not seem to activate AHR signaling during the early phase of infection, which is consistent with the observation that AHR-inducible genes such as Cyp1a1 (encoding cytochrome P4501A1) were not upregulated in response to VSV infection, whereas interferon-inducible genes, including Oas1a and Rsad2, were induced ( Supplementary Fig. 2d ). Taken together, these results indicate that constitutive activation of AHR signaling by endogenous ligands modulates IFN-I production pathway in vitro and in vivo during viral infection.
AHR negatively regulates antiviral response via TIPARP To clarify whether this suppressive effect is mediated directly or indirectly through ligand-dependent activation of AHR, we used cycloheximide (CHX) as a protein synthesis inhibitor. We found that Kyn did not suppress 3pRNA-induced Ifnb1 mRNA induction ( Supplementary Fig. 2e ), suggesting that Kyn negatively regulates the interferon response possibly via induction of one or more AHR target genes. We next examined the possible involvement of several representative AHR-inducible genes in the suppression of 3pRNA-induced interferon response by knockdown using small interfering RNAs (siRNAs) in MEFs ( Supplementary Fig. 2f ). Knockdown of TIPARP (siTIPARP) abolished the suppressive effect of Kyn on Ifnb1 induction in MEFs (Fig. 3a) . These results suggest that TIPARP may be a key mediator in AHR signaling to negatively modulate virally induced interferon response. We focused on TIPARP because it catalyzes ADP-ribosylation of proteins and is classified in the CCCH-poly(ADP-ribose) polymerase (CCCH-PARP) subfamily 6, [39] [40] [41] [42] , another member of which, ZC3HAV1, engages in host defense against viral infection 41, 42 . We observed upregulation of Tiparp mRNA in mouse and TIPARP mRNA in human cells after treatment with endogenous AHR ligands Kyn or FICZ ( Fig. 3b and Supplementary Fig. 2g ). The expression of mRNA encoding other representative PARP family members (Parp1, Parp2, Parp9, Parp12 and Zc3hav1) was not increased after treatment with Kyn or FICZ (Supplementary Fig. 2h ). In addition, we observed upregulation of TIPARP in vivo in FICZ-treated wild-type C57BL/6N mice ( Supplementary Fig. 2i ). We also found that the expression of Tiparp mRNA was abolished in Ahr −/− MEFs, suggesting that the induction of TIPARP is dependent on AHR (Fig. 3c) . To examine the functional role of TIPARP in the IFN-I production pathway, we exogenously expressed TIPARP in HEK293T cells, which resulted in suppression of interferon response to NDV infection (Fig. 3d ) or 3pRNA stimulation ( Supplementary Fig. 3a,b) . No such effect was observed for IL-1β−induced IL8 expression in HEK293T cells (Supplementary Fig. 3c ). IFNB1 mRNA was strongly upregulated by knockdown of TIPARP expression in HEK293T cells treated with 3pRNA ( Supplementary Fig. 3d ). This siRNA-mediated effect was rescued by expression of mouse TIPARP (Fig. 3e) , which was not targeted by this siRNA but was functional in human cells (data not shown).
We further analyzed TIPARP-deficient (Tiparp −/− ) MEFs to investigate the role of TIPARP in negatively regulating the IFN-I response. Ifnb1 mRNA and IFN-β protein were considerably upregulated in Tiparp −/− MEFs (compared with wild-type MEFs) after stimulation with all of the nucleic acid ligands tested (Fig. 4a,b and Supplementary  Fig. 3e ). Consistent with these results, the IFN-β response was enhanced in Tiparp −/− MEFs after infection with NDV, FluV and VSV (which activate RIG-I); EMCV (which activates melanoma differentiation-associated protein Mda5) and HSV-1 (which activates cGAS) 36, 43 (Fig. 4c,d ). The IFN-β response in Tiparp −/− BMDMs was also enhanced, as compared with wild-type cells, upon FluV infection or poly(rI:rC) stimulation ( Fig. 4e and Supplementary Fig. 3f ). These findings are in line with the observation that viral titers at 24 h after infection with any of these viruses were much lower in Tiparp −/− MEFs than in wild-type MEFs (Fig. 4f) . Taken together, our data indicate that TIPARP functions as a critical regulator to suppress the interferon antiviral response activated by nucleic acid sensors after infection with a wide range of viruses.
TIPARP suppresses TBK1 activity via ADP-ribosylation Next, we examined which step of the RIG-I signaling pathway TIPARP acts on. Activation of the IFNB1 promoter by overexpression of N-terminal RIG-I and its adaptor MAVS or the downstream TBK1 was markedly suppressed in TIPARP-expressing HEK293T cells, whereas such suppression was not observed with overexpression of a constitutively active IRF-3 mutant (IRF-3/5D) 44 (Fig. 5a) . Moreover, the TBK1-induced dimer formation of IRF-3, a key transcription factor for interferon induction 27 
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A r t i c l e s compared with wild-type MEFs (Fig. 5b) . This suggests that TIPARP acts on TBK1 to suppress IFN-I induction. Therefore, we focused on the involvement of TIPARP in TBK1 activation to further determine the molecular mechanism underlying the TIPARP-involved regulation of nucleic acid-triggered signaling. Because TIPARP is an enzyme that post-translationally modifies itself and other proteins, including AHR 39,40 , we further investigated the relationship between TIPARP and TBK1, including their physical interaction. Endogenous TBK1, but not IRF-3, interacted with endogenous TIPARP after 3pRNA stimulation (Fig. 5c) . In addition, recombinant TIPARP protein was pulled down with recombinant TBK1 protein, which indicates a direct interaction between these proteins (Supplementary Fig. 4a ). Consistent with these findings, confocal microscopy revealed that YFP-tagged TIPARP colocalized with endogenous TBK1 in the perinuclear region in a ligand-dependent manner ( Fig. 5d and Supplementary Fig. 4b ).
We next performed nuclear and cytosolic protein fractionation to examine the distribution of TIPARP after 3pRNA stimulation. 3pRNA stimulation resulted in increased TIPARP protein in the cytosolic fraction, which was reduced by treatment with leptomycin B, an inhibitor of nuclear export (Supplementary Fig. 4c ). This suggests that 3pRNA stimulation at least partly facilitates the nuclear export of TIPARP, which is then able to interact with and regulate TBK1 activity. An N-terminal TBK1 mutant encompassing only its kinase domain (TBK1(KD)) showed much stronger binding activity to HA-tagged TIPARP than did the full-length TBK1 (TBK1(WT)) or a C-terminal mutant (TBK1(ULD+CC)) ( Supplementary Fig. 4d ), which suggests that this interaction is predominantly mediated through the TBK1 kinase domain. On the other hand, the coimmunoprecipitation with several TIPARP deletion mutants showed that the C-terminal TIPARP region containing all of the known domains (C-TIPARP) but not its N-terminal 236-aa region (N-TIPARP) is required for the interaction with TBK1 (Supplementary Fig. 4e ). We next determined whether TIPARP regulates the autophosphorylation of TBK1 at S172, which is crucial for its activation 45 . Time-course analysis showed that both S172 of TBK1 and S396 of IRF-3 were phosphorylated to a greater degree in Tiparp −/− MEFs than in wild-type MEFs after VSV infection A r t i c l e s or 3pRNA stimulation ( Fig. 5e and Supplementary Fig. 4f) . As reported 40 , TIPARP showed auto-mono-ADP-ribosyltransferase activity. Recombinant TBK1 protein underwent ADP-ribosylation in the presence of recombinant intact TIPARP (rGST-TIPARP(WT)) but not the catalytically inactive mutant rGST-TIPARP(H532A) (Fig. 5f) , suggesting that the ADP-ribosylation of TBK1 is dependent on the catalytic activity of TIPARP. In addition, TBK1 was ADP-ribosylated in virally infected or 3pRNA-stimulated wild-type MEFs, whereas ADP-ribosylation was not detected in Tiparp −/− MEFs ( Fig. 5g and  Supplementary Fig. 5a,b) . We also determined that the TBK1(KD) was ADP-ribosylated by TIPARP (Supplementary Fig. 5c ), suggesting that the ADP-ribosylation of TBK1(KD) might hinder the autophosphorylation of TBK1. Consistent with these results, incubation of TBK1 with rGST-TIPARP(WT) but not rGST-TIPARP(H532A) resulted in suppression of autophosphorylation (at S172) of TBK1 (Fig. 5h) . This result prompted us to further investigate whether the suppressive effect of TIPARP on the interferon response is based on its enzymatic activity. Whereas the reconstitution of wild-type TIPARP in Tiparp −/− MEFs could rescue the knockout phenotype for IFN-I response to FluV infection or ligand stimulation (3pRNA, poly(rI:rC) or dsVACV 70-mer), the enzymatic inactive mutant TIPARP(H532A) did not ( Fig. 5i and Supplementary Fig. 5d,e) . Consistent with this, virus titers were also restored by the introduction of intact TIPARP but not the TIPARP(H532A) in Tiparp −/− MEFs (Fig. 5i) . These data suggest that TIPARP modifies TBK1 activity via ADP-ribosylation of the TBK1 protein, resulting in the suppression of IRF-3-mediated IFN-I induction.
AHR-TIPARP axis contributes to IFN-I antiviral response
Last, we determined whether AHR signaling is crucially involved in the regulation of virally induced interferon response through the induction of TIPARP. In contrast to the data above (Fig. 2a,b) , Kyn and FICZ did not suppress Ifnb1 mRNA induction by 3pRNA stimulation or FluV infection in Tiparp −/− MEFs (Fig. 6a) . Additionally, we examined the role of TIPARP, which is induced by constitutive activation of AHR signaling by endogenous ligands (Supplementary Fig. 1h) . We observed that virally induced IFN-β production was not affected by blockade of AHR signaling with CH-223191 in Ahr −/− MEFs or Tiparp −/− MEFs (Fig. 6b) . A similar result was obtained when the Kyn was reduced by treatment with the TDO inhibitor 680C91 Figs. 2b and 5f ). Consistent with these results, FluV titers were not suppressed in Ahr −/− or Tiparp −/− MEFs treated with CH-223191 (Fig. 6c) . Furthermore, i.p. administration of CH-223191 caused a significant decrease (P < 0.01) of Tiparp mRNA in mouse lung tissue (Supplementary Fig. 5g ) and led to enhanced IFN-β production during FluV infection, which was accompanied with significantly lower viral titers and better survival rates compared with controls injected with corn oil (Fig. 6d,e) . We further evaluated Tiparp −/− mice to show the in vivo role of TIPARP in the negative regulation mediated by constitutive AHR signaling. Pharmacological inhibition of AHR signaling by CH-223191 treatment in Tiparp −/− mice did not affect IFN-β production (Fig. 6f) . These results indicate that optimal induction of interferon-mediated antiviral response is dependent on TIPARP expression through constitutive AHR signaling mediated by endogenous ligand(s) (Supplementary Fig. 6 ).
DISCUSSION
This study demonstrates a physiological role of AHR-mediated signaling in the host antiviral defense system. Our analyses with AHRdeficient cells reveal that the AHR is a key regulator of IFN-I production activated by nucleic acid sensor-mediated signaling during infection with a variety of viruses, suggesting a novel relationship between AHR signaling and innate signaling. In addition, our results indicate that the constitutive AHR signaling mediated by endogenous ligands such as Kyn has a regulatory role in the virally induced interferon response. We also identified TIPARP, an ADP-ribosyltransferase, as a critical target induced by constitutively active AHR signaling. We showed that TIPARP is a suppressive regulator of the TBK1-mediated pathway, a cardinal pathway for interferon induction, possibly via its post-translational modification of the kinase domain of TBK1
by ADP-ribosylation. The kinase domain of TBK1 was shown to be targeted by TIPARP, leading to the suppression of TBK1 activity. The detailed mapping of the ADP-ribosylated sites of TBK1 needs to be clarified. Although TBK1 activity is regulated in a variety of ways, such as phosphorylation and ubiquitination 46 , the ADP-ribosylation of TBK1 described here represents the first report, to our knowledge, of a mechanism for its regulation. In this regard, TIPARP catalytic activity could be a therapeutic target to modulate TBK1 kinase activity for the control of inflammation and cancer. This study shows the physiological importance of AHR-regulated TIPARP expression in tuning the interferon response against viral infection, indicating a novel aspect of constitutive AHR signaling in innate immunity. Mechanisms must be in place to prevent deleterious host reactions to microbial infection, such as superfluous activation of inflammation or cytokine storms 31 . Our findings suggest that constitutive AHR signaling may help to protect the host from harmful effects caused by excessive IFN-I activation by modulating TIPARP expression to downregulate activation of TBK1 induced by the innate sensing of viral MAMPs, which are abundantly generated during infection with most viruses. Alternatively, our results suggest the possibility that AHR activation by intrinsic factors produced after stress or by nutritional dysregulation is responsible for the attenuation of innate resistance against viral infection. Our findings may thus have clinical applications, particularly for controlling pathological innate immune responses. In addition, our analyses with an AHR antagonist, a TDO inhibitor and an IDO inhibitor suggest that this constitutive AHR signaling is dependent on endogenous ligands including, possibly, tryptophan metabolites. It will be important to identify these endogenous AHR ligands and any factors that regulate tryptophan metabolism. 
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Given the constraining effect of AHR-induced TIPARP in virally induced interferon responses, the AHR-TIPARP axis may be hijacked on exposure to xenobiotic AHR ligands such as TCDD or 3-MC, which could explain their immunotoxicity 22, 23 . The role of AHR during viral infection has so far been investigated mainly on the basis of analyses with exogenous ligands such as TCDD. Mouse survival rates after influenza virus infection are reduced by TCDD-induced AHR activation 22, 23 . TCDD increases the replication of human cytomegalovirus, possibly through the dependence on AHR 47 . 3-MC induces the reactivation of HIV-1 replication 48 . These inhibitory effects on viral infection could be explained by the AHR-TIPARP-dependent regulatory mechanism, as viral MAMPs derived from FluV, human cytomegalovirus and HIV-1 have been reported to activate the RIG-I-or the TBK1-interferon pathway in certain cell types 43, 49, 50 . However, a large number of studies have shown regulatory roles for the AHR not only in xenobiotic detoxification but also in cell proliferation and tumorigenesis 4 , and type I interferons are pleiotropic cytokines with antiviral, antitumor and immunomodulatory properties. It will therefore be interesting to investigate the relevance of the AHR-TIPARP-dependent interferon regulation to oncogenesis, tumor progression and immune surveillance.
Collectively, our results provide an association between endogenously activated AHR signaling and innate-sensor-mediated interferon response, which is coupled by TIPARP. Taking into account the other regulatory roles of endogenous AHR signaling in adaptive immunity [7] [8] [9] , pharmacological modification of AHR or TIPARP activity would, therefore, serve as a rational clinical approach for the control of viral infection, inflammation, cancer and, possibly, other diseases.
METHODS
Methods and any associated references are available in the online version of the paper. with both YFP-tagged TIPARP and mCherry-tagged TBK1 expression vector, and then FRET analysis was performed with IX81 fluorescence microscope (Olympus). We used the following filters in this study: BP490-500HQ (Olympus) and FF01-542/27-25 (Semrock) excitation/emission filters for the YFP images; BP535-555HQ and BA570-625HQ (Olympus) for mCherry; and BP490-500HQ and BP590 for FRET. As a dichroic mirror, a DM505HQ glass reflector (Olympus) was used. FRET c = FRET -0.1041 × YFP -0.0199 × mCherry, where FRET, YFP and mCherry indicate fluorescence intensities acquired for the FRET, YFP and RFP channels, respectively, with the background fluorescence intensity subtracted. FRET efficiency was calculated as a quotient of background-subtracted FRET and YFP images, and was presented in an intensity-modified display mode with MetaMorph software. In the intensity-modified display mode shown in Supplementary Figure 4b , eight colors from red to blue are used to represent the emission ratio, with the intensity of each color.
Nuclear-cytosolic protein fractionation. 6 × 10 5 cells of HEK293T cells were seeded on 6-well plates and transfected with 1.0 µg HA-tagged TIPARP expression vector. Twenty-four hours later, these cells were pretreated with leptomycin B (200 µg/ml) for 2 h then stimulated with 3pRNA (10 µg/ml) for 4 h. Nuclear-cytosolic protein fractionation was performed according to the manufacturer's protocol (CelLytic NuCLEAR Extraction Kit; Sigma).
Purification of recombinant proteins. GST and GST-tagged TBK1 (WT, KD, or ULD+CC), TIPARP and TIPARP(H532A) were expressed in Sf9 cells according to the manufacturer's instructions for Bac-to-Bac baculovirus expression system (Invitrogen) and purified with glutathione Sepharose 4B (GE Healthcare). GST protein of recombinant GST-TBK1 was cleaved with Precision protease (GE Healthcare).
